down arrow

Daito Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3486150000
  • TKS: 4577
JPY
1,350.00
17 (1.28%)

Sep 24

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
May'26
Feb'26
Nov'25
Aug'25
May'25
Feb'25
Nov'24
Net Sales
13,918.00
11,591.00
12,130.00
13,011.00
14,034.00
12,025.00
11,906.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
13,918.00
11,591.00
12,130.00
13,011.00
14,034.00
12,025.00
11,906.00
Raw Material Cost
11,138.00
9,239.00
9,923.00
10,453.00
11,772.00
10,028.00
9,777.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
34.00
33.00
33.00
30.00
38.00
34.00
34.00
Selling and Distribution Expenses
1,896.00
1,226.00
1,580.00
1,558.00
1,510.00
1,600.00
1,507.00
Other Expenses
-3.40
-3.30
-3.30
-3.00
-3.80
-3.40
-3.40
Total Expenditure (Excl Depreciation)
13,034.00
10,465.00
11,503.00
12,011.00
13,282.00
11,628.00
11,284.00
Operating Profit (PBDIT) excl Other Income
884
1126
627
1000
752
397
622
Other Income
-13.00
343.00
182.00
9.00
-1.00
37.00
-101.00
Operating Profit (PBDIT)
1,985.00
2,612.00
1,897.00
2,051.00
1,875.00
1,539.00
1,582.00
Interest
34.00
33.00
33.00
30.00
38.00
34.00
34.00
Exceptional Items
-42.00
0.00
2.00
76.00
-164.00
129.00
2.00
Gross Profit (PBDT)
2,780.00
2,352.00
2,207.00
2,558.00
2,262.00
1,997.00
2,129.00
Depreciation
1,114.00
1,143.00
1,088.00
1,042.00
1,124.00
1,105.00
1,061.00
Profit Before Tax
796.00
1,435.00
780.00
1,054.00
549.00
530.00
487.00
Tax
-71.00
386.00
236.00
377.00
-127.00
158.00
247.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
893.00
1,036.00
536.00
696.00
691.00
309.00
291.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
893.00
1,036.00
536.00
696.00
691.00
309.00
291.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-27.00
14.00
8.00
-20.00
-16.00
63.00
-50.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
866.00
1,050.00
544.00
676.00
675.00
372.00
241.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
52,892.00
52,262.00
52,168.00
52,173.00
52,003.00
51,530.00
52,013.00
Earnings per share (EPS)
30.96
35.2
18.11
23.21
22.87
10.16
9.48
Diluted Earnings per share
30.96
35.2
18.11
23.21
22.87
10.16
9.48
Operating Profit Margin (Excl OI)
6.35%
9.71%
5.17%
7.69%
5.36%
3.3%
5.22%
Gross Profit Margin
13.72%
22.24%
15.4%
16.11%
11.92%
13.6%
13.0%
PAT Margin
6.42%
8.94%
4.42%
5.35%
4.92%
2.57%
2.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended May 2026 is -0.83% vs 14.72% in May 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended May 2026 is 28.30% vs -25.66% in May 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended May 2026 is 6.50% vs 1.46% in May 2025

stock-summary

Interest

YoY Growth in quarter ended May 2026 is -10.53% vs 100.00% in May 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended May 2026 has improved from May 2025

Compare Quarterly Results Of Daito Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
13,918.00
0.00
13,918.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
13,918.00
0.00
13,918.00
Raw Material Cost
11,138.00
23.29
11,114.71
47,723.10%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
34.00
8.48
25.52
300.94%
Selling and Distribution Expenses
1,896.00
387.84
1,508.16
388.86%
Other Expenses
-3.40
53.70
-57.10
-106.33%
Total Expenditure (Excl Depreciation)
13,034.00
956.60
12,077.40
1,262.53%
Operating Profit (PBDIT) excl Other Income
884.00
-956.60
1,840.60
192.41%
Other Income
-13.00
14.57
-27.57
-189.22%
Operating Profit (PBDIT)
1,985.00
-918.74
2,903.74
316.06%
Interest
34.00
8.48
25.52
300.94%
Exceptional Items
-42.00
0.00
-42.00
Gross Profit (PBDT)
2,780.00
-23.29
2,803.29
12,036.45%
Depreciation
1,114.00
23.29
1,090.71
4,683.17%
Profit Before Tax
796.00
-950.51
1,746.51
183.74%
Tax
-71.00
4.97
-75.97
-1,528.57%
Provisions and contingencies
0
0
0.00
Profit After Tax
893.00
-955.49
1,848.49
193.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
893.00
-955.49
1,848.49
193.46%
Share in Profit of Associates
0
0
0.00
Minority Interest
-27.00
0.00
-27.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
866.00
-955.49
1,821.49
190.63%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
52,892.00
11,725.00
41,167.00
351.10%
Earnings per share (EPS)
30.96
-12.24
43.20
352.94%
Diluted Earnings per share
30.96
-12.24
43.20
352.94%
Operating Profit Margin (Excl OI)
6.35%
0.00%
0.00
6.35%
Gross Profit Margin
13.72%
0.00%
0.00
13.72%
PAT Margin
6.42%
0.00%
0.00
6.42%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,391.80 Million
in May 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2026 is 14.74%

stock-summary

YoY Growth in quarter ended May 2026 is -0.83% vs 14.72% in May 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 86.60 Million
in May 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2026 is 59.19%

stock-summary

YoY Growth in quarter ended May 2026 is 28.30% vs -25.66% in May 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 199.80 Million
in May 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2026 is 16.50%

stock-summary

YoY Growth in quarter ended May 2026 is 6.50% vs 1.46% in May 2025

Quarterly - Interest
Interest 3.40 Million
in May 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2026 is 3.03%

stock-summary

YoY Growth in quarter ended May 2026 is -10.53% vs 100.00% in May 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.35%
in May 2026

Figures in %
stock-summary

QoQ Growth in quarter ended May 2026 has improved from Nov 2025

stock-summary

YoY Growth in quarter ended May 2026 has improved from May 2025

Footer loading